Kawakami Mark 4
4 · Arcadia Biosciences, Inc. · Filed Aug 21, 2024
Insider Transaction Report
Form 4
Kawakami Mark
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-08-19+20,000→ 21,487 totalExercise: $2.71Exp: 2034-08-19→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The options were granted on 8/19/2024 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs.